Biohaven Pharmaceutical Holding Company Ltd. Shares | BHVN

Annual Shares Biohaven Pharmaceutical Holding Company Ltd.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
64.7 M	58.7 M	48.5 M	39.2 M	27.8 M	12.6 M	11 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
64.7 M	11 M	37.5 M

Quarterly Shares Biohaven Pharmaceutical Holding Company Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	71 M	70.3 M	66.9 M	65.4 M	65.1 M	62 M	60.1 M	59.7 M	58.7 M	56.4 M	52.3 M	52.1 M	45.2 M	44.2 M	40.9 M	40.1 M	38.9 M	36.8 M	36 M	35.9 M	26 M	13.1 M	13.1 M	13.1 M	12.5 M	11.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
71 M	11.8 M	44.1 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
AnaptysBio ANAB	29 M	$ 51.0	1.83 %	$ 1.48 B	USA
Allakos ALLK	88.8 M	-	-	$ 28.6 M	USA
Black Diamond Therapeutics BDTX	56.9 M	$ 1.88	0.53 %	$ 107 M	USA
Clovis Oncology CLVS	128 M	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	34.4 M	-	-	$ 401 M	USA
Evelo Biosciences EVLO	87.2 M	-	-14.46 %	$ 27.9 M	USA
BioMarin Pharmaceutical BMRN	192 M	$ 60.26	0.06 %	$ 11.6 B	USA
BioNTech SE BNTX	242 M	$ 98.52	0.24 %	$ 23.8 B	Germany
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 2.17	0.46 %	$ 3.57 M	Israel
Freeline Therapeutics Holdings plc FRLN	59.3 M	-	-	$ 384 M	Britain
Genocea Biosciences GNCA	68.6 M	-	-15.0 %	$ 3.04 M	USA
Catalyst Biosciences CBIO	89.3 M	$ 13.99	0.84 %	$ 1.25 B	USA
C4 Therapeutics CCCC	82.9 M	$ 2.98	0.3 %	$ 247 M	USA
Codexis CDXS	87.1 M	$ 1.32	1.09 %	$ 115 M	USA
Amryt Pharma plc AMYT	236 M	-	-	$ 621 M	Britain
Cerus Corporation CERS	191 M	$ 2.62	0.38 %	$ 499 M	USA
G1 Therapeutics GTHX	51.7 M	-	-	$ 370 M	USA
Coherus BioSciences CHRS	117 M	$ 1.13	0.43 %	$ 132 M	USA
Celldex Therapeutics CLDX	66.4 M	$ 31.1	1.16 %	$ 2.07 B	USA
CollPlant Biotechnologies Ltd. CLGN	12.2 M	$ 4.25	3.16 %	$ 51.9 M	Israel
Cellectar Biosciences CLRB	2.61 M	$ 1.8	0.72 %	$ 4.69 M	USA
AbbVie ABBV	1.77 B	$ 264.34	0.09 %	$ 468 B	USA
Humanigen HGEN	89.2 M	-	-81.12 %	$ 4.28 M	USA
Cocrystal Pharma COCP	11.3 M	$ 1.17	1.74 %	$ 13.2 M	USA
AbCellera Biologics ABCL	299 M	$ 12.7	0.4 %	$ 3.79 B	Canada
Abeona Therapeutics ABEO	53 M	$ 5.4	2.65 %	$ 286 M	USA
Collegium Pharmaceutical COLL	31.7 M	$ 22.53	0.2 %	$ 713 M	USA
Corcept Therapeutics Incorporated CORT	104 M	$ 116.1	4.93 %	$ 12.1 B	USA
Фармсинтез LIFE	301 M	-	-	-	Russia
IGM Biosciences IGMS	60.5 M	-	-	$ 76.9 M	USA
IMV IMV	8.34 M	-	-	$ 13.1 M	Canada
Kinnate Biopharma KNTE	46.6 M	-	-	$ 123 M	USA
Cardiff Oncology CRDF	66.8 M	$ 1.24	0.74 %	$ 82.9 M	USA
Checkmate Pharmaceuticals CMPI	21.6 M	-	-	$ 231 M	USA
Corbus Pharmaceuticals Holdings CRBP	13.3 M	$ 7.14	0.19 %	$ 95.1 M	USA
Karuna Therapeutics KRTX	37 M	-	-	$ 12.2 B	USA
Curis CRIS	13.2 M	$ 0.83	1.1 %	$ 10.9 M	USA
CorMedix CRMD	72 K	$ 7.85	1.03 %	$ 565 K	USA
Crinetics Pharmaceuticals CRNX	94.1 M	$ 84.95	0.13 %	$ 7.99 B	USA
CRISPR Therapeutics AG CRSP	89.9 M	$ 54.23	0.23 %	$ 4.88 B	Schweiz
Champions Oncology CSBR	13.8 M	$ 4.9	0.1 %	$ 67.8 M	USA
Chimerix CMRX	89.7 M	-	-	$ 756 M	USA
Corvus Pharmaceuticals CRVS	79 M	$ 11.62	8.21 %	$ 918 M	USA
Cue Biopharma CUE	94.7 M	$ 31.41	1.45 %	$ 2.98 B	USA
CEL-SCI Corporation CVM	8.02 M	$ 1.67	2.38 %	$ 13.4 M	USA
Arbutus Biopharma Corporation ABUS	192 M	$ 4.85	0.2 %	$ 929 M	Canada
Cytokinetics, Incorporated CYTK	120 K	$ 64.66	0.17 %	$ 7.77 M	USA
Daré Bioscience DARE	11.2 M	$ 0.78	4.73 %	$ 8.72 M	USA
Adagene ADAG	59 M	$ 2.93	2.86 %	$ 173 M	China
DiaMedica Therapeutics DMAC	47 M	$ 7.94	1.4 %	$ 373 M	USA